Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2021, 9(10), 519-521
DOI: 10.12691/AJMCR-9-10-11
Original Research

Recurrent Marijuana Induced Myocarditis: A Case Report

Sabina Kumar1, , John Carvalho1, Chukwuemeka Umeh1, Pranav BarveJose Penaherrera2, Ratan Tiwari1 and Shivang Shah3, 4

1Department of Internal Medicine, Hemet Global Medical Center, Hemet, California, USA

23Division of Cardiology, University of California Riverside School of Medicine, Riverside, California, USA

3Divison of Cardiology, Loma Linda University School of Medicine, Loma Linda, California, USA

4Division of Cardiology, University of California Riverside School of Medicine, Riverside, California, USA

Pub. Date: July 01, 2021

Cite this paper

Sabina Kumar, John Carvalho, Chukwuemeka Umeh, Pranav BarveJose Penaherrera, Ratan Tiwari and Shivang Shah. Recurrent Marijuana Induced Myocarditis: A Case Report. American Journal of Medical Case Reports. 2021; 9(10):519-521. doi: 10.12691/AJMCR-9-10-11

Abstract

Thirty-Three states in the US have passed laws to legalize marijuana usage, increasing its prevalence by 50% within the last year. Though society generally regards cannabis as safe, the exponential increase in users can evince dangerous side effects in patients presenting to physicians, such as the case presented below. A 37-year-old female presented to the ED with chest pain and an initial troponin of 24 that peaked at 29. The coronary arteries were found to be angiographically normal. She was discharged without any definitive diagnosis. Now 38, she again presented with complaints of crushing, substernal chest pain radiating down her left arm, unrelieved by nitro. Since the onset of pain, she progressively developed shortness of breath, nausea, diaphoresis, and anxiety, stating that she felt like she “was going to die.” Her presentation and impending sense of doom were ominous harbingers for a myocardial infarction; concerns that were validated with an initial troponin of 11.4. EKG showed normal sinus rhythm with nonspecific ST changes. CT Angiogram showed no evidence of pulmonary thrombo-embolism or dissection. Significant CAD leading to this extent of troponin elevation was not suspected as the patient had a normal angiogram a year prior. Stress-Induced Cardiomyopathy was unlikely based on the unremarkable echocardiogram findings. Coronary-Thrombus was considered, however, the hypercoagulable workup was negative along with lack of coronary thrombus on prior angiogram. Under these circumstances, the only explanation for the extent of troponin elevation was myocarditis. Viral infections are the most common cause of myocarditis, however the patient denied any associated symptoms. After ruling out viral etiologies, we subsequently evaluated and eliminated rheumatological disorders and medication-induced myocarditis. The patient’s history revealed that she led a healthy lifestyle, but had struggled with chronic back pain, which led to her cannabis use. By the time of her admission, she smoked up to 1.5 grams of cannabis a day, and stated that chest pain began immediately following smoking cannabis. Her previous episodes also correlated with her cannabis usage. Given the strong correlation of the patient’s symptoms with cannabis use, we theorized her cardiac stress was resultant from it, and recommended that she discontinue its use. To date there have been four reported cases of cannabis-induced myocarditis, making this a fifth case. Of note, the contaminants of marijuana may be variable and include substances like aluminum from soil or pesticides in grass that could traverse the marijuana plant. Inhaling such components has been correlated with an upregulation of cannabinoid receptors in platelets, vascular smooth muscle, and endothelium. CB1R activation has been observed to induce oxidative stress, inflammation, and fibrosis of the cardiomyocyte. With increased cannabis use, it is imperative that we document adverse events to definitively connect its use to cardiac damage.

Keywords

marijana, myoarditis, cardiomyopathy

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  CDC. Marijuana: How Can It Affect Your Health? 2018. Available from: https://www.cdc.gov/marijuana/health-effects.html.
 
[2]  Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data.
 
[3]  National Academies of Sciences E, and Medicine. (2017). The health effects of cannabis and cannabinoids: Current state of evidence and recommendations for researchexternal icon. Washington, D.C.
 
[4]  Kariyanna PT, Wengrofsky P, Jayarangaiah A, Haseeb S, Salciccioli L, Hegde S, Marmur JD, Soliman Y, Al-Bayati S, McFarlane SI. Marijuana and cardiac arrhythmias: A scoping study. International journal of clinical research & trials. 2019; 4(1).
 
[5]  Kariyanna PT, Chandrakumar HP, Feit A, McFarlane IM. Marijuana-induced coronary vasospasm and myocardial infarction: a case report and review of literature. American journal of medical case reports. 2020; 8(7): 216.
 
[6]  Kariyanna PT, Chandrakumar HP, Chowdhury YS, Jayarangaiah A, Das S, Jayarangaiah A, Salifu MO, McFarlane IM. Marijuana and Coronary Dissection: A Case Report and Review of Literature. American journal of medical case reports. 2021; 9(3): 172.
 
[7]  Rodríguez-Castro CE, Alkhateeb H, Elfar A, Saifuddin F, Abbas A, Siddiqui T. Recurrent myopericarditis as a complication of marijuana use. The American journal of case reports. 2014; 15: 60.
 
[8]  Blauwet LA, Cooper LT. Myocarditis. Progress in cardiovascular diseases. 2010 Jan 1; 52(4): 274-88.
 
[9]  Sagar S, Liu PP, Cooper Jr LT. Myocarditis. The Lancet. 2012 Feb 25; 379(9817): 738-47.
 
[10]  Tournebize J, Gibaja V, Puskarczyk E, Popovic B, Kahn JP. Myocarditis and cannabis: An unusual association. Toxicologie Analytique et Clinique. 2016 Sep 1; 28(3): 236.
 
[11]  Kariyanna PT, Jayarangaiah A, Singh N, Song T, Soroka S, Amarnani A, Ray J, McFarlane SI. Marijuana induced myocarditis: a new entity of toxic myocarditis. American journal of medical case reports. 2018; 6(9): 169.